TGF-β promotes the de-differentiation of human basal breast non-CSCs into CSCs via ZEB1, suggesting that the activation of EMT in cancer cells by TGF-β/ZEB1 is closely linked to the de-differentiation of cancer cells into the CSC state [29]. The gene discussed is TGFB1; the disease is cancer.